Thursday - December 26, 2024

Pharmaceutical Capsules Comprising Lumateperone Mono-Tosylate

2024-10-29

ALEXANDRIA, Virginia, Oct. 29 -- INTRA-CELLULAR THERAPIES, INC., New York, New York has been assigned a patent (No. US 12128043 B2, initially filed March 12, 2024) developed by Peng Li, New Milford, New Jersey, and Robert Davis, San Diego, California, for "Pharmaceutical capsules comprising lumateperone mono-tosylate." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Pharmaceutical Capsules Comprising Lumateperone Mono-Tosylate

Information Request Form

Copyright Targeted News Service 2024